Correlation Between Cardano and Herantis Pharma

Can any of the company-specific risk be diversified away by investing in both Cardano and Herantis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardano and Herantis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardano and Herantis Pharma Oyj, you can compare the effects of market volatilities on Cardano and Herantis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardano with a short position of Herantis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardano and Herantis Pharma.

Diversification Opportunities for Cardano and Herantis Pharma

-0.15

Correlation Coefficient

Cardano  Herantis Pharma

Good diversification

The 3 months correlation between Cardano and Herantis is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Cardano and Herantis Pharma Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Herantis Pharma Oyj and Cardano is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardano are associated (or correlated) with Herantis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Herantis Pharma Oyj has no effect on the direction of Cardano i.e., Cardano and Herantis Pharma go up and down completely randomly.

Pair Corralation between Cardano and Herantis Pharma

Assuming the 90 days trading horizon Cardano is expected to generate 2.45 times more return on investment than Herantis Pharma. However, Cardano is 2.45 times more volatile than Herantis Pharma Oyj. It trades about 0.25 of its potential returns per unit of risk. Herantis Pharma Oyj is currently generating about 0.07 per unit of risk. If you would invest  35.00  in Cardano on October 10, 2024 and sell it today you would earn a total of  60.00  from holding Cardano or generate 171.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.63%
Values	Daily Returns

Cardano  vs.  Herantis Pharma Oyj

Cardano

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cardano are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Cardano exhibited solid returns over the last few months and may actually be approaching a breakup point.

Herantis Pharma Oyj

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Herantis Pharma Oyj are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent technical indicators, Herantis Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cardano and Herantis Pharma

The main advantage of trading using opposite Cardano and Herantis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardano position performs unexpectedly, Herantis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Herantis Pharma will offset losses from the drop in Herantis Pharma's long position.

The idea behind Cardano and Herantis Pharma Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.